Xuan H - Search Results

1

Inhibiting Src-mediated PARP1 tyrosine phosphorylation confers synthetic lethality to PARP1 inhibition in HCC.

Sun C, Jing W, Xiong G, Ma D, Lin Y, Lv X, Zhao Y, Ma X, Zhu L, Shen X, Yang M, Qin Z, Cheng Y, Xuan H, Li T, Han L. Sun C, et al. Among authors: xuan h. Cancer Lett. 2022 Feb 1;526:180-192. doi: 10.1016/j.canlet.2021.11.005. Epub 2021 Nov 8. Cancer Lett. 2022. PMID: 34762994

2

Early Prediction of Severe COVID-19 in Patients by a Novel Immune-Related Predictive Model.

Sun C, Xue M, Yang M, Zhu L, Zhao Y, Lv X, Lin Y, Ma D, Shen X, Cheng Y, Xuan H, Jia X, Li T, Han L. Sun C, et al. Among authors: xuan h. mSphere. 2021 Oct 27;6(5):e0075221. doi: 10.1128/mSphere.00752-21. Epub 2021 Oct 13. mSphere. 2021. PMID: 34643417 Free PMC article.

3

TRIM50 promotes NLRP3 inflammasome activation by directly inducing NLRP3 oligomerization.

Lin Y, Lv X, Sun C, Sun Y, Yang M, Ma D, Jing W, Zhao Y, Cheng Y, Xuan H, Han L. Lin Y, et al. Among authors: xuan h. EMBO Rep. 2022 Nov 7;23(11):e54569. doi: 10.15252/embr.202154569. Epub 2022 Sep 30. EMBO Rep. 2022. PMID: 36178239 Free PMC article.

4

Internalization and intracellular processing of an anti-B-cell lymphoma monoclonal antibody, LL2.

Shih LB, Lu HH, Xuan H, Goldenberg DM. Shih LB, et al. Among authors: xuan h. Int J Cancer. 1994 Feb 15;56(4):538-45. doi: 10.1002/ijc.2910560413. Int J Cancer. 1994. PMID: 8112889

5

A fluorouridine-anti-CEA immunoconjugate is therapeutically effective in a human colonic cancer xenograft model.

Shih LB, Xuan H, Sharkey RM, Goldenberg DM. Shih LB, et al. Among authors: xuan h. Int J Cancer. 1990 Dec 15;46(6):1101-6. doi: 10.1002/ijc.2910460625. Int J Cancer. 1990. PMID: 1701165

6

Anthracycline immunoconjugates prepared by a site-specific linkage via an amino-dextran intermediate carrier.

Shih LB, Goldenberg DM, Xuan H, Lu H, Sharkey RM, Hall TC. Shih LB, et al. Among authors: xuan h. Cancer Res. 1991 Aug 15;51(16):4192-8. Cancer Res. 1991. PMID: 1868440

7

In vitro and in vivo reactivity of an internalizing antibody, RS7, with human breast cancer.

Shih LB, Xuan H, Aninipot R, Stein R, Goldenberg DM. Shih LB, et al. Among authors: xuan h. Cancer Res. 1995 Dec 1;55(23 Suppl):5857s-5863s. Cancer Res. 1995. PMID: 7493360

8

Internalization of an intact doxorubicin immunoconjugate.

Shih LB, Goldenberg DM, Xuan H, Lu HW, Mattes MJ, Hall TC. Shih LB, et al. Among authors: xuan h. Cancer Immunol Immunother. 1994 Feb;38(2):92-8. doi: 10.1007/BF01526203. Cancer Immunol Immunother. 1994. PMID: 8306371 Free PMC article.

9

The advantage of residualizing radiolabels for targeting B-cell lymphomas with a radiolabeled anti-CD22 monoclonal antibody.

Mattes MJ, Shih LB, Govindan SV, Sharkey RM, Ong GL, Xuan H, Goldenberg DM. Mattes MJ, et al. Among authors: xuan h. Int J Cancer. 1997 May 2;71(3):429-35. doi: 10.1002/(sici)1097-0215(19970502)71:3<429::aid-ijc21>3.0.co;2-9. Int J Cancer. 1997. PMID: 9139880

10

S100P is a ferroptosis suppressor to facilitate hepatocellular carcinoma development by rewiring lipid metabolism.

Yang M, Cui W, Lv X, Xiong G, Sun C, Xuan H, Ma W, Cui X, Cheng Y, Han L, Chu B. Yang M, et al. Among authors: xuan h. Nat Commun. 2025 Jan 8;16(1):509. doi: 10.1038/s41467-024-55785-8. Nat Commun. 2025. PMID: 39779666 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

353 results

Search Page

Filters